[Medical management of chronic systolic heart failure].
Galinier
Michel
M
CHU de Rangueil, Federation des services de cardiologie, 31059 Toulouse, Inserm U858, 31432 Toulouse. galinier.m@chu-toulouse.fr
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002908:Chronic Disease; D003404:Creatinine / Q000652:urine; D004232:Diuretics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D054143:Heart Failure, Systolic / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D003404:Creatinine
Traitement médicamenteux de l'insuffisance cardiaque systolique chronique.